Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Filters: 0    Descriptive       Fundamental       Technical       All   
Exchange Index Sector Industry Country
Market Cap. Dividend Yield Float Short Analyst Recom. Option/Short
Earnings Date Average Volume Relative Volume Current Volume Price
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 9 #1
CompanyAviat Networks, Inc.
IndustryCommunication Equipment
Market Cap107.52MEPS (ttm)-0.83
P/E-EPS this Y-361.10%
Forward P/E-EPS next Y90.00%
PEG-EPS past 5Y32.50%
P/S0.31EPS next 5Y12.00%
P/B1.04EPS Q/Q-233.30%
Dividend-Sales Q/Q-21.20%
Insider Own0.40%Inst Own64.30%
Insider Trans-4.97%Inst Trans-15.10%
Short Float1.79%EarningsSep 02/a
Analyst Recom2.00Target Price2.15
Avg Volume493.37K52W Range0.99 - 2.81
15-Sep-14 04:05PMAviat Networks to Present at the Singular Research Conference PR Newswire
11-Sep-14 09:14AMAviat (AVNW) Enters Overbought Territory Zacks
10-Sep-14 09:00AMBATS Wireless and Aviat Networks form High-Capacity Wireless Broadband Solutions Partnership for the Energy Market PR Newswire
09-Sep-14 09:00AMHeavy Reading-Aviat Networks Survey: Mobile Operators See Fixed Enterprise Services As Strategic PR Newswire
05-Sep-14 07:19AMCoverage initiated on Aviat Networks by H.C. Wainwright Briefing.com
03-Sep-14 08:00AMAviat Q4 Loss Wider than Expected, Outlook Optimistic Zacks
02-Sep-14 04:07PMAVIAT NETWORKS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
02-Sep-14 04:05PMAviat Networks Announces Preliminary Fiscal Fourth Quarter and Fiscal Year 2014 Financial Results PR Newswire
02-Sep-14 07:07AMQ4 2014 Aviat Networks, Inc Earnings Release - After Market Close CCBN
27-Aug-14 09:00AMAviat Networks to Present at the Drexel Hamilton Telecom, Media and Technology Conference PR Newswire
Aviat Networks, Inc. designs, manufactures, and sells a range of wireless networking products, solutions, and services in North America and Internationally. It offers point-to-point digital microwave transmission systems for first/last mile access, middle mile/backhaul, and long distance trunking applications. The company's products include network management software solutions to enable operators to deploy, monitor, and manage its systems, as well as third party equipment, such as antennas, routers, and multiplexers to build and deploy a wireless transmission network and a suite of turnkey support services. It also provides broadband wireless access base stations and customer premises equipment for fixed and mobile; point-to-point digital microwave radio systems for access, backhaul, trunking, and license-exempt applications; and supporting network deployments, network expansion, and capacity upgrades. In addition, the company offers various professional services, such as network planning and design, site surveys and builds, systems integration, installation, maintenance, network monitoring, training, and customer services. It serves wireless/mobile service providers, original equipment manufacturers, distributors, and system integrators; and private network users, such as public safety agencies and government institutions; and utility, pipeline, railroad, and other industrial enterprises that operate broadband wireless networks. The company was formerly known as Harris Stratex Networks, Inc. and changed its name to Aviat Networks, Inc. in January 2010. Aviat Networks, Inc. is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stumpe HeinzSVP & Chief Sales OfficerSep 09Sale1.532,4013,674116,980Sep 10 02:18 PM
Elliott Meena L.SVP, Gen. Counsel & SecretarySep 09Sale1.531,5842,42499,632Sep 10 02:19 PM
Madigan JohnVP, Corporate Controller & PAOSep 09Sale1.531,0051,53851,829Sep 10 02:17 PM
Stumpe HeinzSVP & Chief Sales OfficerJun 30Sale1.205,4926,593119,381Jul 01 12:36 PM
Elliott Meena L.SVP, Gen. Counsel & SecretaryJun 30Sale1.202,9063,488101,216Jul 01 12:35 PM
CompanyDyax Corp.
Market Cap1.42BEPS (ttm)-0.14
P/E-EPS this Y13.30%
Forward P/E-EPS next Y31.60%
PEG-EPS past 5Y24.80%
P/S22.12EPS next 5Y18.60%
P/B13.74EPS Q/Q75.00%
Dividend-Sales Q/Q73.50%
Insider Own0.10%Inst Own95.40%
Insider Trans-38.70%Inst Trans0.65%
Short Float5.32%EarningsOct 20
Analyst Recom1.70Target Price12.21
Avg Volume1.07M52W Range5.38 - 11.01
15-Sep-14 07:00AMDyax Corp. Announces Issuance of Two Key U.S. Patents for DX-2930 Business Wire
08-Aug-14 01:04PMDYAX CORP Financials EDGAR Online Financials
01-Aug-14 05:27PMDYAX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
29-Jul-14 04:56PMDYAX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
29-Jul-14 04:01PMDyax Corp. Announces Second Quarter 2014 Financial Results Business Wire
29-Jul-14 07:07AMQ2 2014 Dyax Corp. Earnings Release - Time Not Supplied CCBN
23-Jul-14 08:00AMDyax Corp. Announces Publication of Scientific Data for DX-2930 in Peer-Reviewed Journals Business Wire
15-Jul-14 08:59AMDyax Corp. to Host Second Quarter 2014 Earnings Call and Webcast Business Wire
30-Jun-14 10:09AMToday's Perilous Reversal Stock: Dyax (DYAX) at TheStreet
30-Jun-14 07:27AMDyax Corp. (DYAX) Soars: Stock Rises 12.5% Zacks
Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. The company offers KALBITOR for the treatment of acute attacks of HAE. It is developing DX-2930, a human monoclonal antibody inhibitor of plasma kallikrein, which would be a candidate to prophylactically treat HAE and other PKM disorders. The company distributes KALBITOR through a network of wholesale and specialty pharmacy arrangements. It has agreements with CVie Therapeutics for the development and commercialization of KALBITOR in the treatment of HAE and other angioedema indications in China; and Novellus Biopharma AG for the development and commercialization of KALBITOR for the treatment of HAE and other angioedema indications in Latin America, including Argentina, Brazil, Chile, Colombia, Mexico, and Venezuela. The company also has a strategic collaboration agreement with Sigma-Tau Rare Diseases S.A. to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other therapeutic indications in Europe, North Africa, the Middle East, and Russia. Dyax Corp. was founded in 1989 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KEMPNER THOMAS LDirectorSep 12Sale11.004,90053,900717,120Sep 15 04:29 PM
KEMPNER THOMAS LDirectorSep 11Sale11.007,50082,500722,020Sep 15 04:29 PM
KEMPNER THOMAS LDirectorAug 26Sale10.3937,000384,486729,520Aug 27 04:28 PM
KEMPNER THOMAS LDirectorAug 07Sale9.2533,190306,95449,264Aug 11 04:49 PM
MIGAUSKY GEORGE VEVP & Chief Financial OfficerJun 13Sale8.256,00049,50224,000Jun 17 04:10 PM
TickerKOS [NYSE]
CompanyKosmos Energy Ltd.
IndustryIndependent Oil & Gas
Market Cap3.97BEPS (ttm)0.23
P/E44.57EPS this Y-33.30%
Forward P/E25.69EPS next Y45.62%
PEG1.95EPS past 5Y-4.80%
P/S4.08EPS next 5Y22.85%
P/B3.37EPS Q/Q215.40%
Dividend-Sales Q/Q-22.00%
Insider Own4.50%Inst Own51.20%
Insider Trans-78.48%Inst Trans28.78%
Short Float1.60%EarningsAug 04/b
Analyst Recom2.40Target Price14.18
Avg Volume1.32M52W Range9.24 - 11.60
10-Sep-14 10:15AMInsider Trading Alert - WBMD, OSIS And KOS Traded By Insiders at TheStreet
04-Sep-14 11:21AMCredit Suisse Believes It Pays To Wait On Kosmos Energy Ltd Benzinga
03-Sep-14 10:30AMInsider Trading Alert - KOS, PBCT And CNQR Traded By Insiders at TheStreet
27-Aug-14 08:00AMKosmos Energy to Present at Barclays CEO Energy-Power Conference Business Wire
25-Aug-14 05:00PMWhy the Baupost Group establishes new position in Kosmos Energy Market Realist
12-Aug-14 06:46AMOthers Overlooked Kosmos Energy (KOS), Should You Buy It Now? Zacks
09-Aug-14 01:04PMKOSMOS ENERGY LTD. Financials EDGAR Online Financials
04-Aug-14 11:00AMKosmos Energy Ltd Earnings Call scheduled for 11:00 am ET today CCBN
04-Aug-14 07:07AMQ2 2014 Kosmos Energy Earnings Release - Before Market Open CCBN
04-Aug-14 07:00AMKosmos Energy Announces Second Quarter 2014 Results Business Wire
Kosmos Energy Ltd. explores and produces oil and gas in Africa, Europe, and South America. Its asset portfolio includes production and other projects offshore Ghana, as well as exploration licenses with hydrocarbon potential offshore Ireland, Mauritania, Morocco, and Suriname. The company was founded in 2003 and is based in Hamilton, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TONG CHRISDirectorSep 05Buy9.7710,00097,70098,858Sep 09 03:45 PM
TONG CHRISDirectorSep 05Buy9.771,0009,7701,000Sep 09 03:45 PM
Ball Christopher JamesSVP, Planning and Bus. Dev.Sep 05Buy9.8110,00098,100116,084Sep 09 03:47 PM
Doughty JasonGC & SVP, Legal, HR and Admin.Sep 05Buy9.805,10049,980258,402Sep 09 03:49 PM
Hayes William SSVP, Government AffairsSep 02Sale9.8621,326210,2741,204,177Sep 02 07:45 PM
CompanyMaiden Holdings, Ltd.
IndustryProperty & Casualty Insurance
Market Cap882.58MEPS (ttm)0.83
P/E14.59EPS this Y79.70%
Forward P/E6.82EPS next Y19.77%
PEG1.22EPS past 5Y29.20%
P/S0.41EPS next 5Y12.00%
P/B0.98EPS Q/Q-44.30%
Dividend3.63%Sales Q/Q-46.60%
Insider Own1.00%Inst Own70.20%
Insider Trans8.16%Inst Trans-2.36%
Short Float5.18%EarningsAug 06/a
Analyst Recom1.50Target Price15.17
Avg Volume260.70K52W Range10.07 - 13.24
29-Aug-14 10:00AMMaiden Holdings to Present at the Keefe, Bruyette & Woods Insurance Conference on September 4, 2014 GlobeNewswire
19-Aug-14 01:04PMMAIDEN HOLDINGS, LTD. Financials EDGAR Online Financials
11-Aug-14 04:09PMMAIDEN HOLDINGS, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
11-Aug-14 03:52PMMAIDEN HOLDINGS, LTD. Files SEC form 10-Q, Quarterly Report EDGAR Online
08-Aug-14 08:53AMCompass Point Believes Premium Growth And Loss Ratio Support Thesis For Maiden Benzinga
07-Aug-14 09:30AMMaiden Holdings (MHLD) Q2 Earnings in Line, Revenues Beat Zacks
06-Aug-14 05:24PMMAIDEN HOLDINGS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
06-Aug-14 04:35PMMaiden Holdings, Ltd. Announces Record Quarterly Net Operating Earnings(1) of $28.2 Million or $0.37 Per Diluted Common Share and Operating Return on Common Equity(1) of 13.0% GlobeNewswire
06-Aug-14 07:07AMQ2 2014 Maiden Holdings Ltd Earnings Release - After Market Close CCBN
25-Jul-14 06:02AMMAIDEN HOLDINGS, LTD. Files SEC form 8-K, Other Events EDGAR Online
Maiden Holdings, Ltd., together with its subsidiaries, provides reinsurance solutions to regional and specialty insurers in the United States, Europe, and internationally. The company operates through three segments: Diversified Reinsurance, AmTrust Quota Share Reinsurance, and NGHC Quota Share. The Diversified Reinsurance segment offers property, casualty, accident, and health reinsurance products through the treaties with other insurers on a quota share or excess of loss basis, as well as on a facultative basis primarily through third-party intermediaries and on a direct basis. The AmTrust Quota Share Reinsurance segment provides small commercial business insurance, which includes workers' compensation, commercial package, and other property and casualty insurance products; specialty risk and extended warranty coverage for consumer and commercial goods, as well as custom designed coverage, including accidental damage plans and payment protection plans in connection with the sale of consumer and commercial goods; and specialty program that comprises package products, general liability, commercial auto liability, excess and surplus lines programs, and other specialty commercial property and casualty insurance to small and middle market companies. The NGHC Quota Share segment reinsures personal lines automobile business under the quota share reinsurance agreement. The company also offers credit life reinsurance. The company was founded in 2007 and is headquartered in Hamilton, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHMITT KARENChief Financial OfficerSep 03Option Exercise4.0024,17596,610111,324Sep 03 04:03 PM
NEFF RAYMOND MICHAELDirectorMar 27Option Exercise0.0024,0000249,000Mar 28 06:55 AM
MARSHALECK JOHNCHIEF FINANCIAL OFFICERMar 21Option Exercise3.2825,00082,00079,730Mar 24 05:04 PM
RASCHBAUM ARTURO MANUELPRESIDENT AND CEOFeb 18Option Exercise0.00136,6050270,892Feb 20 04:20 PM
TickerMR [NYSE]
CompanyMindray Medical International Limited
IndustryMedical Instruments & Supplies
Market Cap3.67BEPS (ttm)1.69
P/E18.33EPS this Y24.70%
Forward P/E15.35EPS next Y12.05%
PEG5.12EPS past 5Y14.30%
P/S2.90EPS next 5Y3.58%
P/B2.45EPS Q/Q-3.80%
Dividend1.61%Sales Q/Q8.90%
Insider Own0.43%Inst Own81.70%
Insider Trans-Inst Trans-2.13%
Short Float18.52%EarningsAug 11/a
Analyst Recom2.60Target Price33.48
Avg Volume427.25K52W Range28.54 - 41.98
17-Sep-14 07:47PMTop Foreign Stock Funds at Investor's Business Daily
17-Sep-14 05:00AMQuality Exams at Your Fingertips PR Newswire
09-Sep-14 12:30PMMindray Medical Down to Strong Sell on Weak Q2 Zacks
18-Aug-14 09:30PMAsia Morning Read: Solar Module Shortage, Chinese Hackers at Barrons.com
15-Aug-14 08:01AMThe Zacks Analyst Blog Highlights: ReneSola, eLong, China Unicom Hong Kong, Mindray Medical International and Bitauto Holdings Zacks
12-Aug-14 10:00AMMindray Medical Beats Q2 Earnings by a Penny, Cuts 2014 View Zacks
12-Aug-14 08:00AMMindray Medical International Ltd Earnings Call scheduled for 8:00 am ET today CCBN
11-Aug-14 05:00PMMindray Announces Second Quarter 2014 Financial Results PR Newswire
11-Aug-14 04:20PMStocks squeeze out gains; geopolitics, data eyed at CNBC
11-Aug-14 07:07AMQ2 2014 Mindray Medical International Limited Earnings Release - After Market Close CCBN
Mindray Medical International Limited develops, manufactures, and markets medical devices worldwide. The company operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Support Products segment offers monitoring devices that track the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. Its products include single and multiple-parameter monitors; mobile and portable multifunction monitors; central stations that can collect and display multiple patient data on a single screen; electro-cardiogram monitoring devices; and veterinary monitoring devices. This segment also provides anesthesia machines; defibrillators; surgical equipment, including surgical beds, and surgical lights ceiling pendants; syringes and infusion pumps; and ventilators. The In-Vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment; and in-vitro diagnostic products for laboratories, clinics, and hospitals to perform analysis to detect and quantify substances in patient samples. Its product portfolio consists of hematology analysis products, biochemistry analysis products, immunoassay products, coagulation analysis products, urine sediment analysis products, and microbiology analysis products; and reagents used in in-vitro diagnostic products. The Medical Imaging Systems segment offers ultrasound systems used in medical fields, such as urology, gynecology, obstetrics, and cardiology; digital radiography systems; and magnetic resonance imaging systems. The company also provides orthopedic products, endoscope devices, and healthcare IT solutions. Its markets and sells its products through distributors, as well as directly to hospitals and government agencies. The company was founded in 1991 and is headquartered in Shenzhen, The People's Republic of China.
CompanyRepublic Airways Holdings Inc.
IndustryRegional Airlines
Market Cap596.52MEPS (ttm)1.06
P/E11.26EPS this Y46.00%
Forward P/E8.79EPS next Y1.80%
PEG0.87EPS past 5Y-17.60%
P/S0.44EPS next 5Y13.00%
P/B1.01EPS Q/Q25.80%
Dividend-Sales Q/Q1.90%
Insider Own1.70%Inst Own82.80%
Insider Trans5.99%Inst Trans-4.02%
Short Float3.31%EarningsAug 07
Analyst Recom2.30Target Price13.50
Avg Volume513.24K52W Range7.82 - 13.51
19-Sep-14 09:46AMWill Republic Airways (RJET) Continue to Surge Higher? Zacks
18-Sep-14 03:45PMEmbraer E-175 Jet Wins 50 Republic Airways Orders, Loses 20 Zacks
18-Sep-14 08:07AMRepublic Airways (RJET) Catches Eye: Stock Jumps 10.1% Zacks
18-Sep-14 06:00AMREPUBLIC AIRWAYS HOLDINGS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
17-Sep-14 09:09PM[$$] Republic Airways to Buy 50 Embraer Jets at The Wall Street Journal
17-Sep-14 03:25PMWhy Republic Airways (RJET) Stock Is Up Today at TheStreet
17-Sep-14 09:33AMFlybe reconfigures its fleet by leasing smaller aircraft at Financial Times
17-Sep-14 07:02AMEmbraer to sell 50 E-175 jets to Republic in $2.1 billion deal Reuters
17-Sep-14 02:00AMRepublic Airways to Expand Large Regional Jet Operations with United Airlines Business Wire
08-Sep-14 06:15PMRepublic Airways Holdings Reports August 2014 Traffic Business Wire
Republic Airways Holdings Inc., through its subsidiaries, provides scheduled passenger services. It offers scheduled passenger service on approximately 1,390 flights daily to approximately 118 cities in the U.S. and Canada through fixed-fee flights operated under airline partner brands, including American Eagle, Delta Connection, United Express, and US Airways Express. As of December 31, 2013, the company operated a combined fleet of approximately 258 aircraft. It is also engaged in charter and cargo operations. The company was founded in 1996 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dooley Timothy P.EVP, CFO, Treasurer, SecretarySep 18Sale11.573,00034,71060,000Sep 19 05:06 PM
Dooley Timothy P.EVP, CFO, Treasurer, SecretarySep 17Option Exercise6.323,60022,75266,600Sep 19 05:06 PM
Arnell Lars ErikSVP Corporate DevelopmentSep 17Option Exercise6.323,30020,85658,300Sep 19 05:03 PM
Dooley Timothy P.EVP, CFO, Treasurer, SecretarySep 17Sale11.323,60040,75263,000Sep 19 05:06 PM
Arnell Lars ErikSVP Corporate DevelopmentSep 17Sale11.323,30037,35655,000Sep 19 05:03 PM
CompanySangamo Biosciences Inc.
Market Cap780.09MEPS (ttm)-0.47
P/E-EPS this Y-14.30%
Forward P/E-EPS next Y-16.70%
PEG-EPS past 5Y4.40%
P/S25.08EPS next 5Y-
P/B3.63EPS Q/Q0.00%
Dividend-Sales Q/Q50.70%
Insider Own1.40%Inst Own76.10%
Insider Trans-8.00%Inst Trans1.68%
Short Float13.89%EarningsOct 21/a
Analyst Recom1.80Target Price26.25
Avg Volume775.36K52W Range8.93 - 24.69
15-Sep-14 10:30AMInsider Trading Alert - SPR, RTN And SGMO Traded By Insiders at TheStreet
10-Sep-14 04:40PMSangamo Biosciences, Inc. Is Preparing To Drop Big Benzinga
10-Sep-14 07:00AMSangamo BioSciences Announces Target Date For First IND For Sangamo's In Vivo ZFN Genome-Editing Platform For Monogenic Diseases PR Newswire
09-Sep-14 12:23PMDad-turned-CEO inks Pfizer deal for Duchenne drugs at CNBC
09-Sep-14 09:20AMJ.P. Morgan Sees Sangamo Biosciences, Inc. As Attractive Investment Opportunity Benzinga
08-Sep-14 07:00AMSangamo BioSciences Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple HIV-Infected Subjects Treated with SB-728-T PR Newswire
03-Sep-14 04:02PMSangamo BioSciences Announces Presentation at the 2014 Morgan Stanley Global Healthcare Conference PR Newswire
20-Aug-14 06:59AMWhy Sangamo Biosciences (SGMO) Could Be Positioned for a Surge? Zacks
05-Aug-14 04:02PMSangamo BioSciences Announces Presentation At The 2014 Wedbush Securities Life Sciences Management Access Conference PR Newswire
05-Aug-14 01:04PMSANGAMO BIOSCIENCES INC Financials EDGAR Online Financials
Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP nucleases (ZFNs) proteins, which could be used to modify DNA sequences in various ways; and ZFP transcription factors (ZFP TFs) proteins could be used to turn genes on or off. The company's principal ZFP therapeutic is SB-728-T, a ZFN-modified autologous T-cell product, which is in Phase II and Phase I/II clinical trials for the treatment of human immunodeficiency virus and acquired immunodeficiency syndrome. It also develops CERE-110 that is in Phase II clinical trial for the treatment of Alzheimer's disease. In addition, the company has ZFP therapeutic pre-clinical stage programs for hemophilia A and B, huntington's disease, and hemoglobinopathies; and proprietary programs in the areas of lysosomal storage disorders. Further, it has ZFP therapeutic research stage programs in the areas of other monogenic diseases, including various immunodeficiencies, as well as central nervous system disorders and cancer immunotherapy. The company has collaboration and license agreements with Shire International GmbH and Biogen Idec Inc.; and strategic partnerships with Sigma-Aldrich Corporation, Dow AgroSciences, LLC, Open Monoclonal Technology, Inc., F. Hoffmann-La Roche Ltd, and Hoffmann-La Roche Inc. Sangamo Biosciences, Inc. was founded in 1995 and is headquartered in Richmond, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LANPHIER EDWARD O IIPresident & CEOSep 15Option Exercise4.1125,000102,750320,000Sep 17 08:00 PM
LANPHIER EDWARD O IIPresident & CEOSep 15Sale12.1425,000303,383295,000Sep 17 08:00 PM
Wolff Henry WardExec VP & CFOSep 10Sale12.312,00024,620216,347Sep 12 08:00 PM
ANDO DALE GVP, Therapeutic Dev. & CMOSep 05Option Exercise4.1115,00061,650111,579Sep 05 09:45 PM
ANDO DALE GVP, Therapeutic Dev. & CMOSep 05Sale12.2015,000183,07296,579Sep 05 09:45 PM
TickerSOL [NYSE]
CompanyReneSola Ltd.
IndustrySemiconductor - Specialized
Market Cap320.32MEPS (ttm)-2.36
P/E-EPS this Y-1.10%
Forward P/E10.79EPS next Y1550.00%
PEG-EPS past 5Y-27.00%
P/S0.19EPS next 5Y15.00%
P/B2.03EPS Q/Q104.20%
Dividend-Sales Q/Q2.60%
Insider Own55.27%Inst Own16.00%
Insider Trans-Inst Trans-6.48%
Short Float10.92%EarningsDec 05/b
Analyst Recom3.50Target Price3.00
Avg Volume1.71M52W Range2.18 - 6.00
19-Sep-14 08:20AMThe Zacks Analyst Blog Highlights: China Petroleum and Chemical, China Mobile, Goldman Sachs Group, ReneSola and Baidu Zacks
18-Sep-14 04:20PMReneSola (SOL) to Supply SolarMax Inverters in Australia Zacks
17-Sep-14 03:56AMReneSola Expands Distribution Partnership with SolarMax PR Newswire
12-Sep-14 04:00PMReneSola to Provide 10-MW Solar Modules to Indian Firm Zacks
11-Sep-14 05:22AMChinas ReneSola Supplying Solar Panels for India Power Project at Bloomberg
11-Sep-14 05:00AMReneSola to Supply 10MW DCR Solar Modules to Utility-Scale Project in India PR Newswire
08-Sep-14 11:33AMWhy ReneSola (SOL) Stock Is Rising Today at TheStreet
08-Sep-14 09:40AMWill ReneSola (SOL) Continue to Surge Higher? Zacks
08-Sep-14 01:50AMSasol Headline Earnings Per Share up by 14% to a Record R60,16 PR Newswire
02-Sep-14 04:00AMReneSola to Develop 13MW Solar Farm Project in United Kingdom PR Newswire
ReneSola Ltd, through its subsidiaries, manufactures and sells various solar power products. It operates through two segments, Wafer, and Cell and Module. The company offers virgin polysilicon; mono crystalline and multi crystalline solar wafers; and photovoltaic cells. It also provides mono crystalline and multi crystalline solar modules for use in various residential, commercial, industrial, and other solar power generation systems. In addition, the company offers wafer processing services. It offers its products to the manufacturers of solar cells and modules, distributors, installers, and end users of solar modules. The company operates in Mainland China, Taiwan, Australia, Singapore, Korea, India, Hong Kong, Japan, Germany, Greece, Belgium, Italy, France, the United States, Spain, Czech Republic, England, the Netherlands, and South Africa. ReneSola Ltd was founded in 2005 and is based in Jiashan, the People's Republic of China.
CompanySunPower Corporation
IndustrySemiconductor - Specialized
Market Cap4.81BEPS (ttm)1.39
P/E26.39EPS this Y122.90%
Forward P/E21.31EPS next Y32.79%
PEG0.88EPS past 5Y19.60%
P/S1.93EPS next 5Y30.00%
P/B3.53EPS Q/Q-40.00%
Dividend-Sales Q/Q-11.90%
Insider Own0.50%Inst Own36.40%
Insider Trans-14.37%Inst Trans5.21%
Short Float20.27%EarningsJul 31/a
Analyst Recom2.40Target Price41.18
Avg Volume2.22M52W Range23.10 - 42.07
17-Sep-14 06:11PMCanadian Solar et al.: Solar Lifts on Pipelines, China Prospects at Barrons.com
17-Sep-14 01:03PMCanadian Solar Boosts Module Shipments, Stock Rises at Investor's Business Daily
15-Sep-14 09:06PMSunPower Achieves Production Milestone, Manufacturing its One-Billionth Solar Cell PR Newswire
12-Sep-14 06:20PMAdvance Of Three China Solar Stocks Breaks Tradition at Investor's Business Daily
12-Sep-14 12:06PMPolypore rides electric-car interest, gets nod from Cowen at MarketWatch
05-Sep-14 12:17PMU.S. solar power advances 21% on year at MarketWatch
04-Sep-14 11:00AMVermont's Largest Public Solar Initiative Underway PR Newswire
29-Aug-14 05:51PMSolar Trade Wars Create Uncertainty, Alter Economics at Investor's Business Daily
28-Aug-14 04:15PMSUNPOWER CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligati EDGAR Online
27-Aug-14 10:10AMArizona Primary Clouds Solar Power at The Wall Street Journal
SunPower Corporation, an energy services company, designs, manufactures, and delivers solar systems to residential, commercial, and utility customers. It operates in three segments: the Americas, the EMEA, and the APAC. The company offers solar power products, including panels, balance of system components, and inverters. It also designs, manufactures, and sells high-performance rooftop and ground-mounted solar power systems, as well as utility-scale photovoltaic power plants. In addition, the company offers operations and maintenance services, including remote monitoring, preventative, and corrective maintenance services, as well as rapid-response outage restoration and inverter repair services. Further, it leases solar power systems to residential customers. The company serves investors, financial institutions, project developers, electric utilities, independent power producers, commercial and governmental entities, production home builders, residential owners, and small commercial building owners. SunPower Corporation was incorporated in 1985 and is headquartered in San Jose, California. SunPower Corporation is a subsidiary of Total Energies Nouvelles Activits USA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Branderiz EricSVP & Prin Acct OffSep 17Sale37.271,59459,4080Sep 19 05:21 PM
Branderiz EricSVP & Prin Acct OffSep 14Option Exercise0.003,33403,334Sep 16 06:00 PM
WERNER THOMAS HDirector, Pres and CEOSep 02Sale38.2750,0001,913,365207,934Sep 04 05:56 PM
BODENSTEINER LISA MARIEEVP & General CounselSep 02Sale38.2012,806489,18915,939Sep 04 07:21 PM
Branderiz EricSVP & Prin Acct OffAug 19Sale36.852,07276,3530Aug 21 05:35 PM